{"id":"https://openalex.org/W2005372586","doi":"https://doi.org/10.1159/000335264","title":"Alopecia Areata during Treatment of Psoriasis with Adalimumab and Leflunomide: A Case and Review of the Literature","display_name":"Alopecia Areata during Treatment of Psoriasis with Adalimumab and Leflunomide: A Case and Review of the Literature","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-31","ids":{"openalex":"https://openalex.org/W2005372586","doi":"https://doi.org/10.1159/000335264","mag":"2005372586","pmid":"https://pubmed.ncbi.nlm.nih.gov/22301842"},"language":"en","primary_location":{"id":"doi:10.1159/000335264","doi":"https://doi.org/10.1159/000335264","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000335264","pdf_url":null,"source":{"id":"https://openalex.org/S2715032","display_name":"Skin Pharmacology and Physiology","issn_l":"1422-2868","issn":["1422-2868","1422-2906","1660-5527","1660-5535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin Pharmacology and Physiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005372586"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017277347","display_name":"Raquel Navarro","orcid":"https://orcid.org/0000-0002-7459-7845","observed_orcids":["https://orcid.org/0000-0002-7459-7845"]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R. Navarro","raw_affiliation_strings":["Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034720013","display_name":"Esteban Daud\u00e9n","orcid":"https://orcid.org/0000-0002-0676-1260","observed_orcids":["https://orcid.org/0000-0002-0676-1260"]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Daud\u00e9n","raw_affiliation_strings":["Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102011010","display_name":"Elena M. Gallo","orcid":"https://orcid.org/0000-0002-5605-3246","observed_orcids":["https://orcid.org/0000-0002-5605-3246"]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Gallo","raw_affiliation_strings":["Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079457204","display_name":"Diana Santiago S\u00e1nchez\u2010Mateos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"D. Santiago S\u00e1nchez-Mateos","raw_affiliation_strings":["Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113514021","display_name":"Amaro Garc\u00eda\u2010Diez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Garc\u00eda-Diez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.6251,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.9238653,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"25","issue":"2","first_page":"107","last_page":"110"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alopecia-areata","display_name":"alopecia areata","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9089999794960022},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/leflunomide","display_name":"leflunomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6710000038146973},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8230000138282776},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.5189999938011169},{"id":"https://openalex.org/keywords/drug-induced-alopecia","display_name":"drug-induced alopecia","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C2775905006","wikidata":"https://www.wikidata.org/wiki/Q248550","display_name":"Leflunomide","level":3,"score":0.9630850553512573},{"id":"https://openalex.org/C2777524370","wikidata":"https://www.wikidata.org/wiki/Q5075435","display_name":"Alopecia areata","level":2,"score":0.9185952544212341},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8501319885253906},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.8405420780181885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8291738033294678},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7404775619506836},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.646022617816925},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.5355252027511597},{"id":"https://openalex.org/C3020084786","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor \u03b1","level":3,"score":0.5225039124488831},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.4867744445800781},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.462754487991333},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43256285786628723},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.431194931268692},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.41506001353263855},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.3140357732772827}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077339","descriptor_name":"Leflunomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000506","descriptor_name":"Alopecia Areata","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000335264","doi":"https://doi.org/10.1159/000335264","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000335264","pdf_url":null,"source":{"id":"https://openalex.org/S2715032","display_name":"Skin Pharmacology and Physiology","issn_l":"1422-2868","issn":["1422-2868","1422-2906","1660-5527","1660-5535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin Pharmacology and Physiology","raw_type":"journal-article"},{"id":"pmid:22301842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22301842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin pharmacology and physiology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W138072549","https://openalex.org/W196041567","https://openalex.org/W1971220784","https://openalex.org/W1977964717","https://openalex.org/W2025142050","https://openalex.org/W2058233090","https://openalex.org/W2073808228","https://openalex.org/W2080507561","https://openalex.org/W2085073241","https://openalex.org/W2112405467","https://openalex.org/W2122234395","https://openalex.org/W2141098080","https://openalex.org/W2323939540","https://openalex.org/W2426910491","https://openalex.org/W2766945366"],"related_works":["https://openalex.org/W2083400977","https://openalex.org/W2997944796","https://openalex.org/W2736713079","https://openalex.org/W2029281345","https://openalex.org/W4286843665","https://openalex.org/W2040421623","https://openalex.org/W2328693481","https://openalex.org/W2323939540","https://openalex.org/W4240263452","https://openalex.org/W2386548411"],"abstract_inverted_index":{"The":[0],"pathogenesis":[1],"of":[2,35,58,74,80],"alopecia":[3],"areata":[4],"(AA)":[5],"is":[6,12],"not":[7],"clear,":[8],"even":[9],"though":[10],"it":[11],"believed":[13],"to":[14],"be":[15,83],"an":[16],"autoimmune":[17],"mechanism":[18],"which":[19],"involves":[20],"T":[21],"lymphocytes":[22],"and":[23,41,52,66,77],"cytokines":[24],"such":[25],"as":[26,97],"tumor":[27],"necrosis":[28],"factor":[29],"\u03b1.":[30],"We":[31,54,68],"report":[32],"the":[33,59,72,78],"case":[34,89],"a":[36,56],"43-year-old":[37],"man":[38],"with":[39,50,63],"psoriasis":[40],"psoriatic":[42],"arthritis":[43],"who":[44],"developed":[45],"AA":[46,62,81],"during":[47],"his":[48],"treatment":[49],"adalimumab":[51],"leflunomide.":[53,67],"perform":[55],"review":[57],"literature":[60],"associating":[61],"biological":[64],"therapy":[65],"cannot":[69],"exclude":[70],"that":[71,88],"use":[73],"these":[75],"therapies":[76],"development":[79],"could":[82],"coincidental.":[84],"However,":[85],"we":[86],"consider":[87],"reports":[90],"like":[91],"ours":[92],"are":[93],"essential":[94],"for":[95],"clinicians":[96],"early":[98],"alerts":[99],"if":[100],"similar":[101],"observations":[102],"occur.":[103]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005372586","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
